title: Neonatal hyperbilirubinemia associated with glucose-6-phosphate dehydrogenase deficiency in Sephardic-Jewish neonates: incidence, severity, and the effect of phototherapy.
abstract: Glucose-6-phosphate dehydrogenase (G-6-PD) deficiency is frequently associated with neonatal hyperbilirubinemia, and sometimes kernicterus, often in the absence of any identifiable trigger or hematological evidence of hemolysis. The aim of this study was to compare the incidence and severity of, and the effect of phototherapy on, jaundice in G 6-PD-deficient vs G-6-PD-normal neonates in the Sephardic-Jewish community. Healthy term newborns, born to mothers of families stemming from geographic areas known to be "at risk" for G-6-PD deficiency, were screened for the condition and surveyed for hyperbilirubinemia. Seventy-five G-6-PD-deficient neonates formed the study group, while 266 neonates with normal levels of the enzyme formed the control group. Neonates with any other identifiable cause for jaundice were excluded. Phototherapy was commenced when the serum bilirubin levels reached 16 mg/dL (274 mumol/L) or more, and it was discontinued at 12 mg/dL (205 mumol/L) or less. Hyperbilirubinemia developed in 27 (36%) of the deficient neonates (serum total bilirubin greater than 13.9 mg/dL [238 mumol/L]), compared with 50 (18.8%) of control neonates (P = .002), while 20 (26.7%) of the study group required phototherapy, compared with 31 (11.7%) of control neonates (P = .002). Two neonates in the study group required exchange transfusion (serum bilirubin greater than 20 mg/dL [342 mumol/L]), vs 0 in the control group (not significant).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Neonatology, Shaare Zedek Medical Center, Jerusalem, Israel.
authors.forename: M
authors.initials: M
authors.lastname: Kaplan
authors.forename: A
authors.initials: A
authors.lastname: Abramov
mesh_terms: D001208:Asia / Q000208:ethnology; D001663:Bilirubin / Q000097:blood; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000097:blood / Q000453:epidemiology* / Q000208:ethnology / Q000235:genetics / Q000628:therapy; D006579:Heterozygote; D006801:Humans; D015994:Incidence; D007231:Infant, Newborn; D007557:Israel / Q000453:epidemiology; D007567:Jaundice, Neonatal / Q000097:blood / Q000453:epidemiology* / Q000208:ethnology / Q000628:therapy; D007585:Jews; D008297:Male; D010789:Phototherapy; D011446:Prospective Studies; D012737:Sex Factors; D013997:Time Factors
chemical_list: D001663:Bilirubin